WARF currently is working with more than 50 active start-ups whose business markets include therapeutics, research tools, biotechnology, medical devices, food and agriculture, engineering, computer, stem cell and clean technologies. WARF currently holds equity in more than 30 of these companies. Some of WARF's start-up companies have achieved IPO status as publicly-traded companies and have been acquired by large, well established companies, such as Roche and Hologic.
Successful Exits
 |
Hologic holds the number one position in nine technology areas serving woman's health, including breast cancer diagnosis and treatment, cervical cancer screening, prenatal testing, and osteoporosis detection. We believe that the health issues facing women today deserve and demand the singular dedication of a passionate company.
 |
Roche NimbleGen, Inc. is a leading innovator, manufacturer and supplier of a proprietary suite of DNA microarrays, consumables, instruments and services.
 |
Mirus Bio LLC is a life science company focused on discovering, developing and commercializing innovative nucleic acid based technologies and products.
Mirus R&D uniquely integrates nucleic acid delivery and chemistry, a core competency which is unmatched in the industry. This serves as the foundation for its novel research reagents.
